Clinical Trial Update: Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX) [Phase 3]

View source ↗

Summary

This document provides long-term follow-up results from participants in the REFLEX Phase 3 trial investigating treatment for multiple sclerosis and clinically i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinically Isolated Syndrome
• Multiple Sclerosis

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Multiple Sclerosis, Clinically Isolated Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2013-10-28